Study suggests new molecular strategy for treating fragile X syndrome
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
The Pharma Letter4 天
Fragile X syndrome market to quadruple to $111.9 million in USA and Germany by 2030
According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...
AZoLifeSciences on MSN16 小时
Targeting NMDA Receptor Subunit Shows Promise for Fragile X Syndrome
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
GEN1 天
Fragile X Phenotypes Reversed in Mice by Targeting NMDA Receptors
MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.
MIT Neuroscientists Discover a Tiny Brain Receptor That Could Transform Fragile X Treatment
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
US and German FXS market forecast to grow by combined $83.2m from 2025 to 2030
A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...
Stock prices and home values have created a ‘wealth effect,’ but the market is fragile ...
Surging stock prices and house values have fueled a remarkable increase in household wealth. Household net worth — the ...
Equities Analysts Issue Forecasts for AVXL Q2 Earnings
Stock analysts at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for shares of Anavex Life Sciences in ...